▶ 調査レポート

呼吸器疾患治療の世界市場2019-2027:疾患別(喘息、慢性閉塞性肺疾患[COPD]、肺癌、呼吸器感染症、アレルギー性鼻炎、嚢胞性線維症[CF]、その他)、薬物クラス別、投与経路別、流通経路別

• 英文タイトル:Respiratory Disorders Treatment Market (Disease: Asthma, Chronic Obstructive Pulmonary Disease [COPD], Lung Cancer, Respiratory Tract Infection, Allergic Rhinitis, Cystic Fibrosis [CF], and Others; Drug Class: Bronchodilators, Corticosteroids, Combination Drugs, Antibiotics, Target Therapy, Immunotherapy, CFTR, and Others; Route of Administration: Oral, Nasal, and Injectable; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Transparency Market Researchが調査・発行した産業分析レポートです。呼吸器疾患治療の世界市場2019-2027:疾患別(喘息、慢性閉塞性肺疾患[COPD]、肺癌、呼吸器感染症、アレルギー性鼻炎、嚢胞性線維症[CF]、その他)、薬物クラス別、投与経路別、流通経路別 / Respiratory Disorders Treatment Market (Disease: Asthma, Chronic Obstructive Pulmonary Disease [COPD], Lung Cancer, Respiratory Tract Infection, Allergic Rhinitis, Cystic Fibrosis [CF], and Others; Drug Class: Bronchodilators, Corticosteroids, Combination Drugs, Antibiotics, Target Therapy, Immunotherapy, CFTR, and Others; Route of Administration: Oral, Nasal, and Injectable; and Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027 / TMR2006019資料のイメージです。• レポートコード:TMR2006019
• 出版社/出版日:Transparency Market Research / 2020年3月
• レポート形態:英文、PDF、182ページ
• 納品方法:Eメール
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥620,065 (USD5,795)▷ お問い合わせ
  Multi User¥941,065 (USD8,795)▷ お問い合わせ
  Corporate License¥1,262,065 (USD11,795)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、呼吸器疾患治療の世界市場について、序論、仮定・調査手法、エグゼクティブサマリー、市場動向、キーインサイト、疾患別(喘息、慢性閉塞性肺疾患[COPD]、肺癌、呼吸器感染症、アレルギー性鼻炎、嚢胞性線維症[CF]、その他)分析、薬物クラス別分析、投与経路別分析、流通経路別分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ)分析、競争状況などを総合的に調査・分析して掲載しております。
・序論
・仮定・調査手法
・エグゼクティブサマリー
・市場動向
・キーインサイト
・呼吸器疾患治療の世界市場規模:疾患別(喘息、慢性閉塞性肺疾患[COPD]、肺癌、呼吸器感染症、アレルギー性鼻炎、嚢胞性線維症[CF]、その他)
・呼吸器疾患治療の世界市場規模:薬物クラス別
・呼吸器疾患治療の世界市場規模:投与経路別
・呼吸器疾患治療の世界市場規模:流通経路別
・呼吸器疾患治療の世界市場規模:地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東アフリカ)
・競争状況

Respiratory Disorders Treatment Market – Scope of the Report

TMR’s report on the global respiratory disorders treatment market studies past as well as current growth trends and opportunities to gain valuable insights of these indicators for the market during the forecast period from 2019 to 2027. The report provides revenue of the global respiratory disorders treatment market for the period from 2017 to 2027, considering 2018 as the base year and 2027 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global respiratory disorders treatment market during the forecast period.

The report has been prepared after primary and secondary researches. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global respiratory disorders treatment market.

Secondary research also includes Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global respiratory disorders treatment market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on changing competitive dynamics in the global respiratory disorders treatment market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global respiratory disorders treatment market.

The report delves into the competitive landscape of the global respiratory disorders treatment market. Key players operating in the global respiratory disorders treatment market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global respiratory disorders treatment market that have been profiled in this report.

Key Questions Answered in Respiratory Disorders Treatment Market Report

What is the scope of growth of combination drugs in the global respiratory disorders treatment market?
What will be the Y-o-Y growth of the global respiratory disorders treatment market between 2019 and 2027?
What is the influence of changing trends in target therapies on the global respiratory disorders treatment market?
Will North America continue to be the most profitable regional market for respiratory disorders treatment providers?
Which factors are anticipated to hamper the growth of the global respiratory disorders treatment market during the forecast period?
Which are the leading companies in the global respiratory disorders treatment market?
Research Methodology

A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global respiratory disorders treatment market. This research methodology is a combination of primary and secondary researches, which helps analysts to warrant the accuracy and reliability of the drawn conclusions.

Secondary methods referred to by analysts during the production of the global respiratory disorders treatment market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the respiratory disorders treatment market.

These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the respiratory disorders treatment market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global respiratory disorders treatment market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future projection of the global respiratory disorders treatment market more reliably and accurately.

レポート目次

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Respiratory Disorders Treatment Market

4. Market Overview

4.1. Introduction

4.1.1. Route of Administration Definition

4.1.2. Industry Evolution / Developments

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Respiratory Disorders Treatment Market Analysis and Forecast, 2017–2027

4.4.1. Market Revenue Projections (US$ Bn)

4.5. Porter’s Five Force Analysis

5. Key Insights

5.1. Health Care Industry Overview

5.2. Health Care Industry Overview

5.3. Pipeline Analysis (asthma, lung cancer, COPD)

5.4. Disease Prevalence Rate in Key Countries

5.5. Disease Management

5.6. Key Market Events

5.7. Regulatory Scenario

5.8. Reimbursement Scenario

5.9. Technological Advancements

6. Global Respiratory Disorders Treatment Market Analysis and Forecast, by Drug Class

6.1. Introduction & Definition

6.1.1. Key Findings / Developments

6.2. Global Respiratory Disorders Treatment Market Value Forecast, by Drug Class, 2017–2027

6.2.1. Bronchodilators

6.2.2. Corticosteroids

6.2.3. Combination Drugs

6.2.4. Antibiotics

6.2.5. Target Therapy

6.2.6. Immunotherapy

6.2.7. CFTR

6.3. Others Global Respiratory Disorders Treatment Market Attractiveness Analysis, by Drug Class

7. Global Respiratory Disorders Treatment Market Analysis and Forecast, by Disease

7.1. Introduction & Definition

7.1.1. Key Findings / Developments

7.2. Global Respiratory Disorders Treatment Market Value Forecast, by Disease, 2017–2027

7.2.1. Asthma

7.2.2. Chronic Obstructive Pulmonary Disease (COPD)

7.2.3. Lung Cancer

7.2.4. Respiratory Tract Infection

7.2.5. Allergic Rhinitis

7.2.6. Cystic Fibrosis (CF)

7.2.7. Others

7.3. Global Respiratory Disorders Treatment Market Attractiveness Analysis, by Disease

8. Global Respiratory Disorders Treatment Market Analysis and Forecast, by Route of Administration

8.1. Introduction & Definition

8.1.1. Key Findings / Developments

8.2. Global Respiratory Disorders Treatment Market Value Forecast, by Route of Administration, 2017–2027

8.2.1. Oral

8.2.2. Nasal

8.2.3. Injectable

8.3. Global Respiratory Disorders Treatment Market Attractiveness Analysis, by Route of Administration

9. Global Respiratory Disorders Treatment Market Analysis and Forecast, by Distribution Channel

9.1. Introduction & Definition

9.1.1. Key Findings / Developments

9.2. Global Respiratory Disorders Treatment Market Value Forecast, by Distribution Channel, 2017–2027

9.2.1. Hospital Pharmacies

9.2.2. Retail Pharmacies

9.2.3. Online Pharmacies

9.3. Global Respiratory Disorders Treatment Market Attractiveness Analysis, by Distribution Channel

10. Global Respiratory Disorders Treatment Market Analysis and Forecast, by Region

10.1. Key Findings

10.2. Global Respiratory Disorders Treatment Market Value Forecast, by Region

10.2.1. North America

10.2.2. Europe

10.2.3. Asia Pacific

10.2.4. Latin America

10.2.5. Middle East & Africa

10.3. North America Respiratory Disorders Treatment Market Attractiveness Analysis, by Region

11. North America Respiratory Disorders Treatment Market Analysis and Forecast

11.1. Introduction

11.1.1. Key Findings

11.2. North America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Drug Class, 2017–2027

11.2.1. Bronchodilators

11.2.2. Corticosteroids

11.2.3. Combination Drugs

11.2.4. Antibiotics

11.2.5. Target Therapy

11.2.6. Immunotherapy

11.2.7. CFTR

11.3. North America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Disease, 2017–2027

11.3.1. Asthma

11.3.2. Chronic Obstructive Pulmonary Disease (COPD)

11.3.3. Lung Cancer

11.3.4. Respiratory Tract Infection

11.3.5. Allergic Rhinitis

11.3.6. Cystic Fibrosis (CF)

11.3.7. Others

11.4. North America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Route of Administration, 2017–2027

11.4.1. Oral

11.4.2. Nasal

11.4.3. Injectable

11.5. North America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2027

11.5.1. Hospital Pharmacies

11.5.2. Retail Pharmacies

11.5.3. Online Pharmacies

11.6. North America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Country, 2017–2027

11.6.1. U.S.

11.6.2. Canada

11.7. North America Respiratory Disorders Treatment Market Attractiveness Analysis

11.7.1. By Drug Class

11.7.2. By Disease

11.7.3. By Route of Administration

11.7.4. By Distribution Channel

11.7.5. By Country

12. Europe Respiratory Disorders Treatment Market Analysis and Forecast

12.1. Europe Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Drug Class, 2017–2027

12.1.1. Bronchodilators

12.1.2. Corticosteroids

12.1.3. Combination Drugs

12.1.4. Antibiotics

12.1.5. Target Therapy

12.1.6. Immunotherapy

12.1.7. CFTR

12.2. Europe Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Disease, 2017–2027

12.2.1. Asthma

12.2.2. Chronic Obstructive Pulmonary Disease (COPD)

12.2.3. Lung Cancer

12.2.4. Respiratory Tract Infection

12.2.5. Allergic Rhinitis

12.2.6. Cystic Fibrosis (CF)

12.2.7. Others

12.3. Europe Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Route of Administration, 2017–2027

12.3.1. Oral

12.3.2. Nasal

12.3.3. Injectable

12.4. Europe Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2027

12.4.1. Hospital Pharmacies

12.4.2. Retail Pharmacies

12.4.3. Online Pharmacies

12.5. Europe Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2027

12.5.1. Germany

12.5.2. U.K.

12.5.3. France

12.5.4. Spain

12.5.5. Italy

12.5.6. Rest of Europe

12.6. Europe Respiratory Disorders Treatment Market Attractiveness Analysis

12.6.1. By Drug Class

12.6.2. By Disease

12.6.3. By Route of Administration

12.6.4. By Distribution Channel

12.6.5. By Country/Sub-region

13. Asia Pacific Respiratory Disorders Treatment Market Analysis and Forecast

13.1. Asia Pacific Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Drug Class, 2017–2027

13.1.1. Bronchodilators

13.1.2. Corticosteroids

13.1.3. Combination Drugs

13.1.4. Antibiotics

13.1.5. Target Therapy

13.1.6. Immunotherapy

13.1.7. CFTR

13.2. Asia Pacific Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Disease, 2017–2027

13.2.1. Asthma

13.2.2. Chronic Obstructive Pulmonary Disease (COPD)

13.2.3. Lung Cancer

13.2.4. Respiratory Tract Infection

13.2.5. Allergic Rhinitis

13.2.6. Cystic Fibrosis (CF)

13.2.7. Others

13.3. Asia Pacific Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Route of Administration, 2017–2027

13.3.1. Oral

13.3.2. Nasal

13.3.3. Injectable

13.4. Asia Pacific Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2027

13.4.1. Hospital Pharmacies

13.4.2. Retail Pharmacies

13.4.3. Online Pharmacies

13.5. Asia Pacific Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2027

13.5.1. China

13.5.2. Japan

13.5.3. India

13.5.4. Australia & New Zealand

13.5.5. Rest of Asia Pacific

13.6. Asia Pacific Respiratory Disorders Treatment Market Attractiveness Analysis

13.6.1. By Drug Class

13.6.2. By Disease

13.6.3. By Route of Administration

13.6.4. By Distribution Channel

13.6.5. By Country/Sub-region

14. Latin America Respiratory Disorders Treatment Market Analysis and Forecast

14.1. Latin America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Drug Class, 2017–2027

14.1.1. Bronchodilators

14.1.2. Corticosteroids

14.1.3. Combination Drugs

14.1.4. Antibiotics

14.1.5. Target Therapy

14.1.6. Immunotherapy

14.1.7. CFTR

14.2. Latin America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Disease, 2017–2027

14.2.1. Asthma

14.2.2. Chronic Obstructive Pulmonary Disease (COPD)

14.2.3. Lung Cancer

14.2.4. Respiratory Tract Infection

14.2.5. Allergic Rhinitis

14.2.6. Cystic Fibrosis (CF)

14.2.7. Others

14.3. Latin America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Route of Administration, 2017–2027

14.3.1. Oral

14.3.2. Nasal

14.3.3. Injectable

14.4. Latin America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2027

14.4.1. Hospital Pharmacies

14.4.2. Retail Pharmacies

14.4.3. Online Pharmacies

14.5. Latin America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2027

14.5.1. Brazil

14.5.2. Mexico

14.5.3. Rest of Latin America Latin America

14.6. Latin America Respiratory Disorders Treatment Market Attractiveness Analysis

14.6.1. By Drug Class

14.6.2. By Disease

14.6.3. By Route of Administration

14.6.4. By Distribution Channel

14.6.5. By Country/Sub-region

15. Middle East & Africa Respiratory Disorders Treatment Market Analysis and Forecast

15.1. Middle East & Africa Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Drug Class, 2017–2027

15.1.1. Bronchodilators

15.1.2. Corticosteroids

15.1.3. Combination Drugs

15.1.4. Antibiotics

15.1.5. Target Therapy

15.1.6. Immunotherapy

15.1.7. CFTR

15.2. Middle East & Africa Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Disease, 2017–2027

15.2.1. Asthma

15.2.2. Chronic Obstructive Pulmonary Disease (COPD)

15.2.3. Lung Cancer

15.2.4. Respiratory Tract Infection

15.2.5. Allergic Rhinitis

15.2.6. Cystic Fibrosis (CF)

15.2.7. Others

15.3. Middle East & Africa Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Route of Administration, 2017–2027

15.3.1. Oral

15.3.2. Nasal

15.3.3. Injectable

15.4. Middle East & Africa Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2027

15.4.1. Hospital Pharmacies

15.4.2. Retail Pharmacies

15.4.3. Online Pharmacies

15.5. Middle East & Africa Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2027

15.5.1. GCC Countries

15.5.2. South Africa

15.5.3. Rest of Middle East & Africa

15.6. Middle East & Africa Respiratory Disorders Treatment Market Attractiveness Analysis

15.6.1. By Drug Class

15.6.2. By Disease

15.6.3. By Route of Administration

15.6.4. By Distribution Channel

15.6.5. By Country/Sub-region

16. Competition Landscape

16.1. Market Player – Competition Matrix (by Tier and Size of companies)

16.2. Market Share / Position Analysis, by Company, 2018

16.3. Competitive Business Strategies

16.4. Company Profiles

16.4.1. GlaxoSmithKline plc

16.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.1.2. Growth Strategies

16.4.1.3. SWOT Analysis

16.4.2. Merck & Co., Inc.

16.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.2.2. Growth Strategies

16.4.2.3. SWOT Analysis

16.4.3. AstraZeneca

16.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.3.2. Growth Strategies

16.4.3.3. SWOT Analysis

16.4.4. Boehringer Ingelheim International GmbH

16.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.4.2. Growth Strategies

16.4.4.3. SWOT Analysis

16.4.5. Novartis AG

16.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.5.2. Growth Strategies

16.4.5.3. SWOT Analysis

16.4.6. F. Hoffmann-La Roche Ltd.

16.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.6.2. Growth Strategies

16.4.6.3. SWOT Analysis

16.4.7. Teva Pharmaceutical Industries Ltd.

16.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.7.2. Growth Strategies

16.4.7.3. SWOT Analysis

16.4.8. Sanofi

16.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.8.2. Growth Strategies

16.4.8.3. SWOT Analysis

16.4.9. Cipla, Inc.

16.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.9.2. Growth Strategies

16.4.9.3. SWOT Analysis

16.4.10. Sun Pharmaceutical Industries Ltd.

16.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.10.2. Growth Strategies

16.4.10.3. SWOT Analysis

16.4.11. Mylan N.V.

16.4.11.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.11.2. Growth Strategies

16.4.11.3. SWOT Analysis

16.4.12. Takeda Pharmaceutical Company Limited

16.4.12.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.12.2. Growth Strategies

16.4.12.3. SWOT Analysis

16.4.13. CHIESI Farmaceutici S.p.A.

16.4.13.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.13.2. Growth Strategies

16.4.13.3. SWOT Analysis

16.4.14. Orion Corporation

16.4.14.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.14.2. Growth Strategies

16.4.14.3. SWOT Analysis

16.4.15. Vertex Pharmaceutical

16.4.15.1. Company Overview (HQ, Business Segments, Employee Strength)

16.4.15.2. Growth Strategies

16.4.15.3. SWOT Analysis

List of Tables

Table 01: Global Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Drug Class, 2017–2027

Table 02: Global Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Disease, 2017–2027

Table 03: Global Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Route of Administration, 2017–2027

Table 04: Global Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2027

Table 05: Global Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Region, 2017–2027

Table 06: North America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Country, 2017–2027

Table 07: North America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Drug Class, 2017–2027

Table 08: North America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Disease, 2017–2027

Table 09: North America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Route of Administration, 2017–2027

Table 10: North America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2027

Table 11: Europe Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2027

Table 12: Europe Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Drug Class, 2017–2027

Table 13: Europe Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Disease, 2017–2027

Table 14: Europe Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Route of Administration, 2017–2027

Table 15: Europe Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2027

Table 16: Asia Pacific Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2027

Table 17: Asia Pacific Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Drug Class, 2017–2027

Table 18: Asia Pacific Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Disease, 2017–2027

Table 19: Asia Pacific Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Route of Administration, 2017–2027

Table 20: Asia Pacific Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2027

Table 21: Latin America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2027

Table 22: Latin America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Drug Class, 2017–2027

Table 23: Latin America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Disease, 2017–2027

Table 24: Latin America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Route of Administration, 2017–2027

Table 25: Latin America Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2027

Table 26: Middle East & Africa Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017–2027

Table 27: Middle East & Africa Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Drug Class, 2017–2027

Table 28: Middle East & Africa Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Disease, 2017–2027

Table 29: Middle East & Africa Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Route of Administration, 2017–2027

Table 30: Middle East & Africa Respiratory Disorders Treatment Market Value (US$ Bn) Forecast, by Distribution Channel, 2017–2027